✦ LIBER ✦

O-032 Neoadjuvant therapy with docetaxel and cisplatin in patients with non-small cell lung cancer (NSCLC), stage IIIA, pN2: A large phase II study with 59 months of follow-up

✍ Scribed by Betticher, D.; HsuSchmitz, S.; Roth, A.; Spiliopoulos, A.; Pless, M.; Stahel, R.; Weder, W.; Schmid, R.; Cerny, T.; Ris, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant therapy with Docetaxel (TAX)

✍ Betticher, D.C; Hsu Schmitz, S.-F; Gauthier, Y; von Briel, C; Roth, A; Spiliopou 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

P-591 Concurrent chemoradiotherapy (CTRT

✍ Huber, Rudolf M.; Flentje, Michael; Willner, J.; Borgmeier, Astrid; Schmidt, Mic 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Concurrent Chemoradiation Therapy With D

✍ Rudolf M. Huber; Astrid Borgmeier; Michael Flentje; Jochen Willner; Michael Schm 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 379 KB

Phase II study of induction chemotherapy

✍ van Kooten, M; Rosenberg, M; Morero, J; Vilanova, M; Rojas, O; Vicente, H; Silva 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

A phase II study of docetaxel (taxotere)

✍ Kim, H.K; Lee, K.S; Kim, J.S; Kim, Y.K; Park, H.S; Chung, T.J; Lee, S.N; Kang, K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Phase II study of docetaxel and cisplati

✍ H. Okamoto; K. Watanabe; Y. Segawa; Y. Ichinose; A. Yokoyama; S. Yoneda; H. Niit 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 86 KB